Another dual PI3K/mTOR inhibitor, PI-103, an effective monotherapy for glioma [34], was recently shown to specifically reduce tumor volumes in combination with Neural stem cell delivered s-trail in an orthotopic intracranial xenograft model [34]. This evidence concerns the gene PIK3CA and central nervous system cancer.